Efecto de las variaciones iónicas, la osmolaridad y el pH sobre la recuperación del bloqueo neuromuscular no despolarizante por atracurio y vecuronio
暂无分享,去创建一个
[1] L. Skovgaard,et al. Good clinical research practice in pharmacodynamic studies of neuromuscular blocking agents II: the Stockholm revision , 2007, Acta anaesthesiologica Scandinavica.
[2] Z. Salihoğlu,et al. Effect of pneumoperitoneum on the level of plasma potassium. , 2007, Middle East journal of anaesthesiology.
[3] T. Ye,et al. [Effect of neostigmine on atracurium-induced neuromuscular blockage in patients pretreated with magnesium sulphate]. , 2005, Zhongguo yi xue ke xue yuan xue bao. Acta Academiae Medicinae Sinicae.
[4] J. Sugawara,et al. Prolonged relaxant effects of vecuronium in patients with deliberate hypermagnesemia: time for caution in cesarean section , 2005, Journal of Anesthesia.
[5] W. Fawcett,et al. Recurarization in the recovery room following the use of magnesium sulphate. , 2003, British journal of anaesthesia.
[6] Muhammad Jaffar,et al. Reduced duration of muscle relaxation with rocuronium in a normocalcemic hyperparathyroid patient , 2003, Canadian journal of anaesthesia = Journal canadien d'anesthesie.
[7] A. Denault,et al. Magnesium potentiates neuromuscular blockade with cisatracurium during cardiac surgery , 2003, Canadian journal of anaesthesia = Journal canadien d'anesthesie.
[8] Hiroshi Iwasaki,et al. Respiratory acidosis prolongs, while alkalosis shortens, the duration and recovery time of vecuronium in humans. , 2002, Journal of clinical anesthesia.
[9] F. Xue,et al. Influence of acute normovolaemic haemodilution on the dose‐response and time‐course of action of atracurium Note , 2000, Acta anaesthesiologica Scandinavica.
[10] S. Bai,et al. The Infusion Rate of Mivacurium and Its Spontaneous Neuromuscular Recovery in Magnesium-Treated Parturients , 1998, Anesthesia and analgesia.
[11] G. Shorten,et al. Administration of magnesium sulphate before rocuronium: effects on speed of onset and duration of neuromuscular block. , 1997, British journal of anaesthesia.
[12] L. Skovgaard,et al. Good Clinical Research Practice (GCRP) in pharmacodynamic studies of neuromuscular blocking agents , 1996, Acta anaesthesiologica Scandinavica.
[13] Y. Ohta,et al. Effect of hypothermia on the in vitro potencies of neuromuscular blocking agents and on their antagonism by neostigmine. , 1994, British journal of anaesthesia.
[14] D. Sessler. Consequences and treatment of perioperative hypothermia , 1994 .
[15] J. Wierda,et al. Pharmacodynamic behaviour of vecuronium in primary hyperparathyroidism , 1994, Canadian journal of anaesthesia = Journal canadien d'anesthesie.
[16] M. Sharma,et al. Cumulative Characteristics of Atracurium and Vecuronium: A Simultaneous Clinical and Pharmacokinetic Study , 1994, Anesthesiology.
[17] T. Heier,et al. Mild Intraoperative Hypothermia Does Not Change the Pharmacodynamics (Concentration‐Effect Relationship) of Vecuronium in Humans , 1994, Anesthesia and analgesia.
[18] J. Hunter,et al. Effect of age, gender and anaesthetic technique on the pharmacodynamics of atracurium. , 1993, British Journal of Anaesthesia.
[19] A. Namiki,et al. [Vecuronium-induced neuromuscular blockade in two patients with hyperparathyroidism and a patient with hypoparathyroidism]. , 1992, Masui. The Japanese journal of anesthesiology.
[20] N. Hirsch,et al. Effect of arterial carbon dioxide tension on the duration of action of atracurium. , 1991, British journal of anaesthesia.
[21] T. Heier,et al. Mild intraoperative hypothermia increases duration of action and spontaneous recovery of vecuronium blockade during nitrous oxide-isoflurane anesthesia in humans. , 1991, Anesthesiology.
[22] K. Bíró. Effects of respiratory and metabolic alkalosis and acidosis on pipecuronium neuromuscular block. , 1988, European journal of pharmacology.
[23] Y. Ohta,et al. THE INFLUENCE OF RESPIRATORY AND METABOLIC ACID-BASE CHANGES ON THE NEUROMUSCULAR EFFECTS OF NONDEPOLARIZING MUSCLE RELAXANTS , 1988 .
[24] Y. Ohta,et al. The Influence of Respiratory‐induced Acid‐base Changes on the Action of Non‐depolarizing Muscle Relaxants in Rats , 1988, Anesthesiology.
[25] W. Buzello,et al. Unequal effects of cardiopulmonary bypass-induced hypothermia on neuromuscular blockade from constant infusion of alcuronium, d-tubocurarine, pancuronium, and vecuronium. , 1987, Anesthesiology.
[26] M. Naguib,et al. Abnormal responses to muscle relaxants in a patient with primary hyperparathyroidism. , 1986, Anesthesiology.
[27] B. Walton,et al. Use of atracurium in cardiac surgery involving cardiopulmonary bypass with induced hypothermia. , 1984, British journal of anaesthesia.
[28] R. Miller,et al. Hypocarbia and Spontaneous Recovery from Vecuronium Neuromuscular Blockade in Anesthetized Patients , 1984, Anesthesia and Analgesia.
[29] H. H. Ali,et al. Evaluation of cumulative properties of three new nondepolarizing neuromuscular blocking drugs BW A444U, atracurium and vecuronium. , 1983, British journal of anaesthesia.
[30] S. Datta,et al. Hypermagnesaemia and anaesthetic management , 1982 .
[31] J. P. Payne,et al. Evaluation of atracurium in anaesthetized man. , 1981, British journal of anaesthesia.
[32] D. Waud,et al. Interaction of calcium and potassium with neuromuscular blocking agents. , 1980, British journal of anaesthesia.
[33] G. Hill,et al. Acute and chronic changes in intra- and extracellular potassium and responses to neuromuscular blocking agents , 1978 .
[34] R. Miller,et al. Diuretic-induced hypokalaemia, pancuronium neuromuscular blockade and its antagonism by neostigmine. , 1978, British journal of anaesthesia.
[35] E. Eger,et al. The effect of acid-base balance on neostigmine antagonism of d-tubocurarine-induced neuromuscular blockade. , 1975, Anesthesiology.
[36] F. Rector,et al. Resting transmembrane potential difference of skeletal muscle in normal subjects and severely ill patients. , 1971, The Journal of clinical investigation.
[37] J. P. Long,et al. The interaction between magnesium and other neuromuscular blocking agents. , 1970, Anesthesiology.